Hims Weight Loss Reviews — Big Brand, Bigger Complaints

Hims (hims.com) is a major publicly traded telehealth company (NYSE: HIMS) that expanded into weight loss in 2023. As part of Hims & Hers Health, it has massive brand recognition, slick marketing, and a dual-track approach offering both injectable GLP-1 medications and oral medication kits. On paper, it sounds impressive. In practice, the picture is far more troubling. With a 3.2/5 Trustpilot rating across 7,608 reviews, pervasive complaints about subscription traps and deceptive billing, an FTC investigation mentioned on ConsumerAffairs, and GLP-1 services unavailable in Texas, New York, California, Florida, and Georgia, Hims has serious issues that its brand name alone cannot fix. Here is our complete analysis.

What Is Hims?

Hims is the men-focused arm of Hims & Hers Health, Inc. (NYSE: HIMS), a publicly traded telehealth company originally known for hair loss and erectile dysfunction treatments. Its counterpart, Hers (forhers.com), serves women. In 2023, Hims entered the GLP-1 weight loss market, leveraging its existing telehealth infrastructure and massive customer base to offer compounded semaglutide, oral medication kits, generic liraglutide, and even brand-name options like Wegovy, Ozempic, Zepbound, and Mounjaro.

The company operates 100% online consultations through its app and website. There are no in-person visits. You answer health questions, a provider reviews your information, and if approved, medication ships to your door. Hims also provides a tracking app with behavioral programs designed to support weight loss alongside medication.

On the surface, Hims looks like a well-resourced, professional operation backed by the credibility of a publicly traded company. But being publicly traded also means aggressive revenue targets, and as we will detail, those pressures appear to have created a business model that prioritizes locking customers into subscriptions over providing straightforward healthcare.

What They Offer

• Compounded semaglutide injectable: $199/month (on 6-month upfront plan) or $399/month (monthly pay)
• Oral Medication Kits: Starting at $69/month (on 10-month upfront plan)
• Generic liraglutide: $299/month (on 12-month upfront plan)
• Brand-name options: Wegovy, Ozempic, Zepbound, Mounjaro (at significantly higher cost)
• 100% online consultations — no in-person visits
• Hims app with tracking and behavioral programs
• FSA/HSA eligible — no separate consultation fees
• Publicly traded company (NYSE: HIMS)

Hims Pricing

Hims advertises its compounded semaglutide "starting at $199/month" — but this number is deeply misleading. That rate only applies if you commit to a 6-month plan paid entirely upfront, meaning you are paying $1,194 before you receive your first injection. If you want to pay monthly without a massive upfront commitment, the actual price is $399/month. That is double the advertised rate and four times what CoreAge Rx charges.

To put this in perspective: CoreAge Rx charges $99/month for compounded semaglutide with no upfront commitment. At Hims, even the "discounted" 6-month rate of $199/month costs $100 more per month — an extra $1,200 per year. And if you pay monthly, you are spending $300 more per month than CoreAge Rx, or $3,600 more per year. The oral medication kits starting at $69/month sound more affordable, but they require a 10-month upfront payment of $690 and are not GLP-1 injectables.

My Experience With Hims

I tested the Hims weight loss onboarding to evaluate the experience firsthand. The results were a mix of polished marketing and frustrating fine print.

Sign-Up Process

The sign-up flow is slick. Hims has invested heavily in its user interface, and it shows. The health questionnaire is well-designed, the branding is consistent, and the entire process feels like a premium tech product. You answer questions about your health history, weight loss goals, and current medications. A provider reviews your information and determines eligibility.

However, this is where the problems start. The pricing presentation is designed to steer you toward the multi-month upfront plans. The "starting at" language is prominent, while the actual monthly rate is buried. Multiple reviewers across Trustpilot and BBB report feeling misled about what they were signing up for and how much they would actually be charged.

The Subscription Problem

This is where Hims loses the most trust. Across every major review platform — Trustpilot, BBB, ConsumerAffairs, and Product Hunt — the single most common complaint is about subscription traps and deceptive billing. Customers report being enrolled in recurring subscriptions they did not knowingly authorize. Cancellation is described as intentionally difficult. One Trustpilot reviewer called the billing practices "super skeezy." BBB complaints describe cancelled orders that still resulted in charges. ConsumerAffairs reviewers use terms like "predatory business model."

Perhaps most concerning: multiple reviewers report being unable to delete their Hims accounts entirely. In an era where data privacy is paramount, the inability to remove your personal health information from a platform you no longer use is a significant red flag.

Customer Support

Customer support receives overwhelmingly negative feedback in reviews. ConsumerAffairs reviewers describe "zero customer support." BBB complaints frequently mention unresponsive support teams and unresolved billing disputes. For a company with the resources of a publicly traded corporation, this level of support failure is inexcusable. When customers cannot get billing issues resolved or cannot cancel unwanted subscriptions, the support infrastructure has fundamentally failed.

Results and Medication Quality

To be fair, some customers do report positive results. One user reported losing over 25% of their body weight in 9 months on the oral medication program. The medications themselves — when they arrive and when the billing works correctly — can be effective. The Hims app with behavioral tracking and support programs adds value for users who engage with it.

However, positive clinical outcomes do not excuse predatory business practices. A medication that works is worthless if you cannot trust the company dispensing it to bill you honestly and let you cancel when you choose.

Pros and Cons

Is Hims Legit?

Hims is a legitimate, publicly traded company — but "legitimate" and "trustworthy" are not the same thing. Being listed on the NYSE means Hims files public financial reports and is subject to SEC oversight. The company is real, the medications are real, and the telehealth services function. In that narrow sense, yes, Hims is legit.

However, legitimacy as a corporation does not mean the business practices are consumer-friendly. The volume and consistency of subscription trap complaints across Trustpilot (3.2/5 with 7,608 reviews), BBB, ConsumerAffairs, and Product Hunt paint a troubling picture. These are not isolated incidents — they represent a pattern of behavior that spans years and thousands of customers.

The ConsumerAffairs mention of an FTC investigation is particularly concerning. While we cannot independently verify the current status of any such investigation, the fact that it has been reported in consumer reviews adds to the overall pattern of concern. The September 2025 FDA warning letter regarding compounded semaglutide products also raises questions about medication safety and regulatory compliance.

• Publicly traded (NYSE: HIMS) — corporate legitimacy established
• Trustpilot: 3.2/5 with 7,608 reviews — mixed at best
• BBB: Multiple complaints about charges on cancelled orders and recurring billing
• ConsumerAffairs: "predatory business model" and FTC investigation reports
• Product Hunt: "overwhelmingly negative" — deceptive subscriptions, poor service
• FDA concerns: Compounded semaglutide not FDA-approved; warning letter issues
• Account deletion impossible according to multiple reviewers

Who Is Hims Best For?

Honestly, it is difficult to recommend Hims for GLP-1 weight loss given the available alternatives. The combination of deceptive pricing, subscription traps, poor customer support, and state restrictions means most patients would be better served elsewhere.

That said, Hims could make sense in a few narrow scenarios: If you specifically want the oral medication kits (starting at $69/month on the 10-month plan) rather than injectables, Hims is one of the few providers offering this option. If you already use Hims for other services (hair loss, ED) and want to consolidate providers, the integrated app experience has some convenience value. Or if you want access to brand-name GLP-1 medications like Wegovy or Zepbound and are willing to pay premium prices, Hims does list those options.

Hims is NOT a good fit if: You live in Texas, New York, California, Florida, or Georgia (GLP-1 services unavailable). You want straightforward, transparent pricing without upfront commitments. You value easy cancellation and responsive customer support. You want the best price for compounded semaglutide (CoreAge Rx is $99/month with no subscription). You are concerned about data privacy and want to be able to delete your account.

Final Verdict: Is Hims Worth It?

Hims is a big brand with big problems. We cannot recommend it as a top GLP-1 provider.

The core issue is trust. When the most consistent theme across 7,608 Trustpilot reviews, BBB complaints, ConsumerAffairs reports, and Product Hunt feedback is that customers feel trapped, overcharged, and unable to get support, that is not a marketing problem — it is a business model problem. The deceptive "$199/month" pricing that actually costs $399 monthly (or requires $1,194 upfront), the subscription traps, the inability to delete accounts, and the reported FTC investigation all point to a company that prioritizes revenue extraction over patient care.

The state restrictions eliminating Texas, New York, California, Florida, and Georgia further limit Hims' utility. And the FDA warning letter concerns regarding compounded semaglutide raise additional safety questions that a company of this size should be better positioned to address.

My recommendation: Skip Hims for GLP-1 weight loss. CoreAge Rx offers compounded semaglutide at $99/month — no upfront commitment, no subscription traps, no account deletion problems. That is $300/month less than Hims' actual monthly rate and $100/month less than even the "discounted" 6-month upfront rate. For a provider that charges four times the price and delivers a fraction of the trust, the math simply does not work.

The Bottom Line

Hims has the brand recognition and resources of a publicly traded company, but its GLP-1 weight loss offering is undermined by deceptive pricing, aggressive subscription practices, terrible customer support, state restrictions covering 40% of the population, and a 3.2/5 Trustpilot rating that reflects widespread consumer dissatisfaction. At $399/month (or $199/month with massive upfront payment), it is dramatically overpriced compared to CoreAge Rx at $99/month. Big names do not always mean better care — and in this case, smaller providers are delivering far more value with far fewer complaints.